Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca recieves planning consent for new global R&D centre and corporate headquarters in Cambridge, UK
-
AstraZeneca announces collaborations to use CRISPR technology for genome editing across its drug discovery platform
AstraZeneca announces collaborations to use CRISPR technology for genome editing across its drug discovery platform
-
Marketing Authorisation Application for gout treatment lesinurad accepted by European Medicines Agency
-
PEGASUS-TIMI 54 study of BRILINTA® meets primary endpoint in both 60mg and 90mg doses
-
MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
-
LYNPARZA™ approved by the US food and drug administration for the treatment of advanced ovarian cancer in patients with germline BRCA-mutations
-
Lynparza™approved in the European Union as first-in-class treatment for advanced BRCA-mutated ovarian cancer
-
AstraZeneca and Amgen to present detailed results from Phase III AMAGINE-1™ study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis
-
MOVENTIG® approved in the European Union for opioid-induced constipation
-
Jury verdict favours AstraZeneca in Nexium antitrust litigation
Latest articles and press releases
All of our latest press releases and articles are available to explore
